Oncology Pharma Inc. (ONPH)
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.
Sector: Shell Companies
Industry: Shell Companies
Oncology Pharma Inc.
OTC:ONPHHealthcare · Biotechnology
+12.50%$0.0405
CLOSED · Nov 16Prev close$0.0360+12.50%Close$0.0405
Mkt Cap$3.33M
EV-
Float15.22M
O/S82.16M
VOL3K sh
$ Vol$115
RVOL0.19×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
MCap$3.33MFloat15.22MO/S82.16M
Dilution
| Form | Description | Links | |
|---|---|---|---|